#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

byKathleen Lau

May 26, 2022

in StudyGraphics

Reading Time: 1 min read

Wellness Check: Sleep

RelatedReports

JAK2 and TET2 mutations temporally linked with myeloproliferative disorder outcomes

Chronic Disease

Momelotinib reduces symptom burden compared to danazol in patients with myelofibrosis

February 8, 2023

Afamelanotide plus UV-B phototherapy effective for vitiligo

Chronic Disease

Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo

October 21, 2022

StudyGraphics

#VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma

May 19, 2022

StudyGraphics

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

May 4, 2022

Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

Parental cannabis use increasing, cigarette use decreasing

Medical cannabis provides little improvement to sleep in chronic pain patients

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

Momelotinib reduces symptom burden compared to danazol in patients with myelofibrosis

Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo

#VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma

Wellness Check: Sleep

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

RelatedReports

Momelotinib reduces symptom burden compared to danazol in patients with myelofibrosis

Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo

#VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

Medical cannabis provides little improvement to sleep in chronic pain patients

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

RELATED REPORTS

Wellness Check: Sleep

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?